Mice with either kinase- or phosphatase-deficient PFK-2 have been demonstrated to develop cardiac hypertrophy at baseline [19,20], suggesting that defective PFK-2 activity per se can drive hypertrophy. The gene discussed is PFKFB3; the disease is cardiac hypertrophy.